Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Christian Kollmannsberger

1-50 of 104 results

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

scientific article published on 25 September 2015

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

scientific article

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

scientific article

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

scientific article published on 16 February 2019

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

scientific article

The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy

scientific article published on 12 November 2010

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

scientific article published on 17 February 2014

Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study

scientific article

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

scientific article published on 26 December 2007

Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database

scientific article published on 28 March 2011

Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer

scientific article published on 24 January 2018

Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance

scientific article

Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.

scientific article published on 08 August 2012

Efficacy of enzalutamide following abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer patients

scientific article published on 10 July 2014

Active surveillance is the preferred approach to clinical stage I testicular cancer

scientific article published on 3 September 2013

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.

scientific article

Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group

scientific article published on July 2007

Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery

scientific article published on 21 December 2009

Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy

scientific article published on 12 March 2010

Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy.

scientific article

First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer: does sequence matter?

scientific article published in March 2006

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer

scientific article published in February 2009

Contemporary management of postchemotherapy testis cancer

scientific article published on 20 August 2012

Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities.

scientific article published on 13 April 2011

Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance

scientific article published on 19 September 2014

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

scientific article

Phase II clinical and pharmacokinetic study of aflibercept in patients with previously treated metastatic colorectal cancer

scientific article

A Phase II Pharmacodynamic Study of Preoperative Figitumumab in Patients with Localized Prostate Cancer

scientific article published on May 2, 2012

Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161)

scientific article published on 28 March 2007

Sequelae of treatment in long-term survivors of testis cancer

scientific article published on 12 June 2011

Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcino

scientific article

Recent advances in management of patients with platinum-refractory testicular germ cell tumors

scientific article

Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors

scientific article published on June 24, 2011

Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium

scientific article published on 15 May 2013

The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium

scientific article

A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer

scientific article published on 29 August 2014

Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity

scientific article published on 30 December 2016

Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer

scientific article published on July 23, 2015

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer.

scientific article

A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium

scientific article published on January 26, 2013

Outcomes with Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Who Have Poor Performance Status

scientific article published in March 2015

The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management

scientific article

Canadian guideline on genetic screening for hereditary renal cell cancers

scientific article published on September 2013

A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma.

scientific article published on 27 December 2013

Canadian consensus guidelines for the management of testicular germ cell cancer

scientific article

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study

scientific article published on 4 April 2018

Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update

scientific article published on May 2015

A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer.

scientific article

Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer

scientific article published on 09 August 2007

Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer

scientific article published on 10 March 2009